Patent Assignment
Reel/Frame 055616/0153
Change of Name
Recorded: 2021-03-17
Pages: 2
Assignor
HEMOGENYX PHARMACEUTICALS LLC
Executed: 2020-08-10
Assignee
HEMOGENYX PHARMACEUTICALS LLC
760 PARKSIDE AVENUE, BROOKLYN, NEW YORK, 11226
Covered Property
(1)
Method of Eliminating Hematopoietic Stem Cells/Hematopoietic Progenitors (Hsc/Hp) in a Patient Using Bi-Specific Antibodies
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.